I am pursuing my PhD at the Leibniz Institute for New Materials in Saarbrucken, Germany. I use microbial synthetic biology to engineer probiotic bacteria to facilitate the production and release of therapeutic compounds in the host’s target site in response to a specific stimulus. Incorporating these engineered bacteria into biocompatible materials enables sustained drug delivery for treating chronic diseases.
I am applied molecular biologist interestes in developing the next generation genetic tool box of different microbial chassis
My family is from Argentina and I grew up as an immigrant in a rural area of an island that belongs to Spain. I love math and biochemistry/biology, science, teaching and learning, helping students succeed. I am an advocate for a friendly, diverse, and safe environment in academia. I am the mother of a wonderful 2-year old boy.
I am a postdoctoral researcher in the Department of Mechanical Engineering at Stanford University, under the guidance of Professor Michaelle Mayalu. I earned my Ph.D. from the Indian Institute of Technology Bombay, specializing in the design of multiplexed biosensors for the ultrasensitive detection of aromatic pollutants in drinking water using synthetic biology principles. Currently, in Professor Mayalu’s lab, my research focuses on designing engineered bacterial circuits to study cell populations through paradoxical feedback loops.
Synthetic Biologist with >10 years of experience. Worked in the Labs of Pamela Silver and Matthew W. Chang. Worked for 8 years at Synlogic, engineering bacteria for clinical stage programs, leading programs and leading the SynBio team. After Synlogic closed I am working now at FieldStone Bio and i am consulting for a few engineered therapeutic microbes companies.
I’m PhD Scholar at IBMS KMU and also virtual teacher for my students. Trying to be a better version of my own and contribute to the society
I am a first-year Ph.D. student in Mark Styczynski’s lab, studying the metabolomics of cell-free protein expression systems. Before this, I did my undergraduate degree at Georgia Tech in ChemE, as well as my masters at MIT, before spending a couple of years working at Sanofi Pharmaceuticals doing cell culture engineering for biotherapeutics. When I’m not in lab, I like to sing and play tennis!
I’m a currently fifth year PhD candidates in the Caroline Ajo-Franklin’s lab at Rice University. My research interests spans synthetic biology, bioelectronics, cell biology, biochemistry, probiotic therapies and diagnosis.
I am a final year PhD candidate researching on establishing de novo biosynthetic routes for synthesis of polyphenols and phenethylamines in bacterial expression systems.
As an engineer and synthetic biologist I’m interested in the intersection of fields and the recontextualization of biology within the engineering space. I believe passionately in a future where the design and implementation of novel genetic systems leads to breakthroughs spanning a multitude of applications.
My name is Mohammad Ali Matinvafa, currently a M.Sc. student in Chemical Engineering
specializing in Biotechnology from Amirkabir University of Technology (AUT), which is one
of the best universities in Iran. I also hold a B.Sc. degree in Biotechnology. I’m expected to defend my
project in Sep 2024.
The subject of my project is “The Study of the Interactions between Therapeutical Molecules
and Non-canonical Nucleic Acid Structures associated with CANVAS Disorder”. The
neurodegenerative disease CANVAS was recently shown to be caused by large repeat expansions
in the RFC1 gene, with the most common pathogenic repeat identified as (AAGGG)n•(CCCTT)n
and the most common non-pathogenic repeat identified as (AAAAG)n•(CTTTT)n. The pathogenic
Repeats form quadruplex or triplex structures (this finding was recently published by our lab
https://doi.org/10.1016/j.jbc.2023.105202). The main hypothesis has been that the difference in
sequence may be the key behind disease pathogenesis. Consequently, it was shown that while the
pathogenic repeats can form non-canonical DNA/RNA structures including G-quadruplexes and
triplexes, this was not observed for the non-pathogenic repeats, showing the disease specificity of
the pathogenic repeats. Here, we aim to study the effect of therapeutical molecules on these
structures using biophysical means including CD spectroscopy, UV spectroscopy, and thermal
melting curves.
additionally, I have 2 published review papers about applications of Biosurfactant in bioremediation of aquatic sites and about applications of CRISPR-Cas9 Technology in green biotechnology. In both, I tried to emphasize the importance of synthetic Biology in enhancing the efficiency of biological systems that finally contribute to greater impacts.
I also have two TA experiences for tow different courses namely Chemistry and Biochemistry of
Biological Molecules, and Industrial Microbiology, Biotechnology & Lab.
I am a Ph.D. candidate in the Solomon Lab at the University of Delaware. I work on characterizing and establishing design rules for the use of plant virus-like particles as nanovaccines.
Miguel Jimenez is an Assistant Professor at Boston University, where he runs el Microbial Integration Group. The group integrates engineered microorganisms with mechanical and electronic devices for applications in human health, agriculture, the environment, and entertainment.
Technology governance is concerned with the decisions that shape how technology is funded, developed, regulated, tested, and deployed – it determines technology trajectories. My social science research takes a critical look at the politics and power in these governance decisions, particularly in efforts to open-up these expert spaces to diverse knowledge, values and visions through engagement and knowledge co-production – features that have become prevalent in technology governance in recent years. I’m particularly interested in the value tensions that exist in and between science and society when governance decisions are opened-up and, importantly, how to manage these tensions more effectively. I focus on the development and risk assessment of emerging technologies, particularly the biotechnologies (gene drive, genome-editing, genetic modification of animals, especially insects) and AL/digital technology applications in environment and agriculture. I am Co-Director of the Centre for Doctoral Training in Environmental Intelligence.
A new report responding to engineering biology’s need for clear standards and metrics to enable the rapid development of a sustainable bioeconomy.
Publication Date: May 2024
Coordinated by Imperial College London, the Engineering Biology Research Consortium (EBRC), the National Institute of Standards and Technology (NIST), and the National University of Singapore (NUS), with support from Schmidt Sciences, this report is a response to the field’s need for standards and metrics and the lack of clarity on which standards to prioritize—from how to catalog organisms used in bioproduction to help make technology transfer more predictable and accurate to making sure data is formatted the same way to enable easier sharing. Representatives from the four partner organizations joined regional stakeholders from the Americas, Europe, and Asia to identify 10 key focus areas. These range from technical areas such as data standards, common definitions, and metrics to quantify and scale up biological processes, to non-technical areas vital for the growth of the bioeconomy, including public engagement and regulatory clarity to aid the safe and efficient commercialization of new products.
Mair earned her B.Sc and M.Sc in Cell and Molecular Biology from Eastern Michigan University where she studied the effects of temperature on kinetics of photorespiratory aminotransferases. She is now perusing a PhD in Plant Molecular and Cellular Biology at the University of Florida where she is being co-supervised by Dr. Hanson and Dr. Voiniciuc. She is interested in researching and engineering cell-wall degrading enzymes using synthetic biology and continuous directed evolution.
I am a second-year PhD student in the Peralta-Yahya lab at Georgia Tech with a focus in metabolic engineering. I work to develop carbon negative chemical production using cell-free CO2 conversion pathways and synthetic carbon conservation networks. I am also interested in the topics of astrobiology and synthetic biology and am passionate about developing biotechnologies to reduce the environmental impact of chemical production.